Large-scale testing (Phase 3)Study completedNCT02417064
What this trial is testing
Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Who this might be right for
Treatment-resistant Depression
Janssen Research & Development, LLC 346